Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Hematol Oncol Clin North Am. 2013 Oct;27(5):905–920. doi: 10.1016/j.hoc.2013.07.007
Tyrosine Kinase Inhibitors
Imatinib*
Sunitinib*
Regorafenib*
Nilotinib*
Sorafenib*
Masitinib
Vatalanib
Dovitinib
Pazopanib*
Cedarinib
Crenolanib

Hsp90 Inhibitors
BIIB021
AT13387
AUY922
Ganestespib (STA-9090)

PI3K–AKT-mTOR inhibitors
Perifosine
Everolimus*
Sirolimus*
Temsirolimus*

Monoclonal Antibodies
Olaratumab

Insulin-like growth factor 1 receptor inhibitors.
OSI-906 (Linsitinib)
*

Commercially available